Device-assisted intravesical chemotherapy versus bacillus Calmette –Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis
ConclusionDevice-assisted intravesical chemotherapy appears to be a safe and viable alternative to BCG for patients with intermediate and high-risk NMIBC, showing comparable oncological outcomes and adverse events.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Allergy | Allergy & Immunology | Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Statistics | Study | Urology & Nephrology